Both in Pharmaceuticals
Protagonist Therapeutics vs BioMarin Pharmaceuticals
Over the past year PTGX returned +87.4% and BMRN returned +8.8%; their daily moves had a correlation of 0.26.
PTGX +87.4% BMRN +8.8%Growth of $1, one year, split-adjusted
| Metric | PTGX | BMRN |
|---|---|---|
| Price | $143.37 | $57.13 |
| Market cap | $9.28B | $11.06B |
| Today | +2.23% | +2.64% |
| 1 month | +3.4% | +1.6% |
| 6 months | +37.9% | +4.6% |
| Year to date | +64.2% | −3.9% |
| 1 year | +88.8% | +8.1% |
| Revenue growth (YoY) | +3749.2% | +19.9% |
| Gross margin | 100.0% | 79.5% |
| Net margin | 76.3% | 4.5% |
| P/E (TTM) | 111.9× | 151.5× |
| Price / sales | 32.9× | 3.2× |
| Net cash | $782.6M | -$3.31B |
| Dividend yield | — | — |
| Volatility (60d) | 32.0% | 27.2% |
| Short % of float | 16.8% | 6.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).